NCT07453394

QLS5132 Combination Therapy in Advanced Solid Tumors

Public trial-level signal summary for this oncology Phase 2 record.

Record overview

Status and phase

Status: NOT_YET_RECRUITING

Phase: PHASE1, PHASE2

Sponsor: Qilu Pharmaceutical Co., Ltd.

Condition: Gastric Cancer (GC), Non-small Cell Lung Cancer (NSCLC), Endometrial Cancer, Advanced Solid Tumors, Ovarian Cancer

Signal summary

Public flags

Status signal: Low Signal

Timeline signals: None

Results signal: Low Signal

Operational burden: large_enrollment_target_signal | few_sites_large_trial_signal | strict_eligibility_signal

Stopped reason

Context when available

No stop reason available in the current public record.